DIA 48th Annual Meeting
Click here to go to the previous page
Approaches to Postapproval Pediatric Safety Surveillance
Track : Track 14: Clinical Safety and Pharmacovigilance
Program Code: 117
Date: Monday, June 25, 2012
Time: 10:00 AM to 11:30 AM  EST
CHAIR :
 Robert Reynolds, Pfizer Inc, United States
PRESENTER (S):
Susan Oliveria, EpiSource, United States
John March, Duke Clinical Research Institute, United States
 Rachel Sobel, Pfizer Inc, United States
Description
This session describes the use of observational data sources and methods, including electronic health care data, cohorts and registries to conduct postapproval safety surveillance in pediatric populations.

Learning Objectives:
Summarize observational methods of postapproval data collection to assess the safety of medicines in children
Compare the feasibility of these approaches under varying scientific and operational circumstances
Apply this knowledge to specific research questions about pediatric medicine safety.